INTERLEUKIN-1 INHIBITS LEYDIG-CELL STEROIDOGENESIS PRIMARILY BY DECREASING 17-ALPHA-HYDROXYLASE C17-20 LYASE CYTOCHROME P450 EXPRESSION

被引:140
作者
HALES, DB
机构
关键词
D O I
10.1210/en.131.5.2165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage-secreted cytokines, such as interleukin-1 (IL-1), have been shown to modulate Leydig cell function. The present study examined the effect of recombinant murine IL-1alpha on Leydig cell steroidogenesis and its mechanism of action. Addition of IL-1 to macrophage-depleted primary cultures of mouse Leydig cells caused a dose-dependent decrease in cAMP-dependent testosterone production and 17alpha-hydroxylase/C17-20 lyase (P450c17) mRNA levels. Chronic treatment (48 h) of Leydig cells in culture with 50 mum 8-bromo-cAMP (8-Br-cAMP) resulted in a 60-fold increase in testosterone production. Treatment with 8-Br-cAMP plus 0.2 and 2 U/ml IL-1 decreased testosterone production to 63 +/- 14% and 41 +/- 19%, respectively, while 5, 10, and 20 U/ml IL-1 decreased testosterone production to less than 5% that of cells treated with 8-Br-cAMP alone. Chronic treatment with IL-1 plus 8-Br-cAMP caused a shift in steroid production from testosterone to progesterone, but total steroid production (the sum of testosterone plus progesterone) was unaffected by IL-1 treatment. Treatment with 8-Br-cAMP alone caused a marked increase in P450c17 mRNA levels compared to that in control cultures, where P450c17 mRNA was undetectable. IL-1 caused a dose-dependent decrease in 8-Br-cAMP-stimulated P450c17 levels (0.2 U/ml by 31 +/- 9%, 2 U/ml by 82 +/- 12%, and 10 or 20 U/ml by 100% compared to that in cells treated with 8-Br-cAMP alone). In contrast to the effect on P450c17 mRNA, only the highest concentrations of IL-1 (10 and 20 U/ml) had any effect on cholesterol side-chain cleavage enzyme (P450scc) mRNA levels (53 +/- 16% and 38 +/- 20% decreases, respectively). The inhibitory effect of IL-1 on 8-Br-cAMP-stimulated P450c17 expression was reversible Within 12 h after the removal of IL-1, P450c17 mRNA was restored to 24%; after 24 h, to 36%; after 36 h, to 65%; and after 48 h, to 84% of that with 8-Br-cAMP alone. P450c17 expression was more sensitive to IL-1-mediated inhibition than P450scc; therefore, inhibition of P450c17 is most likely primarily responsible for the observed inhibitory effects of IL-1 on Leydig cell testosterone production.
引用
收藏
页码:2165 / 2172
页数:8
相关论文
共 35 条
[1]   THE POTENTIAL RELEVANCE OF CYTOKINES TO OVARIAN PHYSIOLOGY - THE EMERGING ROLE OF RESIDENT OVARIAN-CELLS OF THE WHITE BLOOD-CELL SERIES [J].
ADASHI, EY .
ENDOCRINE REVIEWS, 1990, 11 (03) :454-464
[2]   NONCOORDINATE REGULATION OF DENOVO SYNTHESIS OF CYTOCHROME-P-450 CHOLESTEROL SIDE-CHAIN CLEAVAGE AND CYTOCHROME-P-450 17-ALPHA-HYDROXYLASE/C17-20 LYASE IN MOUSE LEYDIG-CELL CULTURES - RELATION TO STEROID-PRODUCTION [J].
ANAKWE, OO ;
PAYNE, AH .
MOLECULAR ENDOCRINOLOGY, 1987, 1 (09) :595-603
[3]  
BRUOT BC, 1992, J ANDROL, V13, P87
[4]   INTERLEUKIN-1 INHIBITS LEYDIG-CELL STEROIDOGENESIS IN PRIMARY CULTURE [J].
CALKINS, JH ;
SIGEL, MM ;
NANKIN, HR ;
LIN, T .
ENDOCRINOLOGY, 1988, 123 (03) :1605-1610
[5]   TUMOR NECROSIS FACTOR-ALPHA ENHANCES INHIBITORY EFFECTS OF INTERLEUKIN-1-BETA ON LEYDIG-CELL STEROIDOGENESIS [J].
CALKINS, JH ;
GUO, H ;
SIGEL, MM ;
LIN, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 166 (03) :1313-1318
[6]   DIFFERENTIAL-EFFECTS OF RECOMBINANT INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA ON LEYDIG-CELL FUNCTION [J].
CALKINS, JH ;
GUO, H ;
SIGEL, MM ;
LIN, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (02) :548-553
[7]  
DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI [10.1016/s0065-2776(08)60642-2, 10.1016/S0065-2776(08)60642-2, DOI 10.1016/S0065-2776(08)60642-2]
[8]   INHIBITORY ACTIONS OF INTERLEUKIN-1-BETA ON STEROIDOGENESIS IN PRIMARY CULTURES OF NEONATAL RAT TESTICULAR CELLS [J].
FAUSER, BCJM ;
GALWAY, AB ;
HSUEH, AJW .
ACTA ENDOCRINOLOGICA, 1989, 120 (04) :401-408
[9]   GLUCOCORTICOID-MEDIATED REPRESSION OF P450SCC MESSENGER-RNA AND DENOVO SYNTHESIS IN CULTURED LEYDIG-CELLS [J].
HALES, DB ;
PAYNE, AH .
ENDOCRINOLOGY, 1989, 124 (05) :2099-2104
[10]  
HALES DB, 1987, J BIOL CHEM, V262, P11200